Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GEMXX Corp. (GEMZ) Continues on Path to Disrupt Gold and Gemstone Industries

Speaking during an October 2023 Bell2Bell Podcast episode, Richard Clowater, the President of GEMXX (OTC: GEMZ), a mine-to-market company that specializes in the production and global distribution of gold, gemstone, and jewelry and owns mining resources, production facilities, and operating assets, underlined that 2021 and 2022 were building years for the company (https://ibn.fm/0xDcQ). “The company […]

SenesTech Inc. (NASDAQ: SNES) Expands Global Distribution with Novel Rodent Birth Control Product Entry Into UAE

Animal pest control innovator SenesTech (NASDAQ: SNES) is expanding distribution of its rodent birth control solution globally, adding the United Arab Emirates (“UAE”) market as the latest entry point for its new Evolve(TM) Soft Bait product. The UAE agreement announced Jan. 2 (https://ibn.fm/pM9to) is part of SenesTech’s new rodent control product distribution agreement through Pesterminators […]

FinovateEurope 2024 To Showcase the New Talents of the Fintech Spectrum

Fintech industry leaders and professionals are invited to FinovateEurope at the Intercontinental O2, London. FinovateEurope is a meticulously curated, fast-paced conference for and by executives of finance verticals. Join the conference to witness global fintech executives offer sharp insights and strategies on the latest trends bracing the industry. Attended by 1000+ decision makers and innovators, […]

Electronic Servitor Publication Network Inc. (XESP) Kicks off Information Campaign Explaining Capabilities of Its Disruptive Digital Engagement Engine(TM)

Electronic Servitor Publication Network (OTCQB: XESP) is pioneering the next step in the evolution of digital marketing through its disruptive technology, the Digital Engagement Engine(TM) (“DE2”), designed to help businesses become more digitally dynamic and profitable. To provide more information about the capabilities of the DE2, XESP is releasing a series of infomercials, the first […]

GEMXX Corp. (GEMZ) Provides Updates on Progress to Acquire 50% Interest in Yukon Gold Project Property as Part of Long-Term Asset Expansion Plan

GEMXX (OTC: GEMZ), a publicly traded, mine-to-market company that focuses on producing gold, gemstone, and jewelry from its own land resources, has this year intensified the execution of its long-term asset expansion plan, initially acquiring a 50% interest in Crazy Horse Mining Inc. (“CHMI”), a Canadian exploration company that owns 100% interest in two gold […]

Astrotech Corp. (NASDAQ: ASTC) Subsidiary AgLAB: Breakthrough Technology For Ag-Distillers

AgLAB, Inc., a subsidiary of Astrotech (NASDAQ: ASTC), has breakthrough mass spectrometry technology in its AgLAB 1000-D2 mass spectrometer and the Maximum Value Process(TM) testing method (“AgLAB MVP”). AgLAB MVP is designed to improve yields and bottom-line profits for hemp (“CBD”) and cannabis (“THC”) producers of CBD-THC oils by up to 30%. Large scale CBD […]

Turbo Energy (NASDAQ: TURB) Grows in Confidence as Energy Transition Relies on AI to Stomp on the Brakes of Global Warming

Turbo Energy (NASDAQ: TURB), a NASDAQ-listed European innovator designing, developing, and manufacturing photovoltaic energy generation, management, and storage equipment, stands to benefit as the world rushes to find solutions to urgent environmental challenges. Global warming intensifies as human activities continue to pump greenhouse gases into the atmosphere. Burning fossil fuels, deforestation, and poor industrial, livestock, […]

Clene Inc. (NASDAQ: CLNN) VISIONARY-MS Trial Data May Support CNM-Au8(R) as Long-Sought-After Multiple Sclerosis Treatment

Clene (NASDAQ: CLNN) and its wholly-owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company recently reported new CNM-Au8(R) results from a long-term open-label extension (“LTE”) of the VISIONARY-MS trial in […]

 

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.